Jawad Alzeer
Dr. Jawad Alzeer hails from Hebron, Palestine. He completed his secondary education at Alhusein High School before pursuing higher studies. Graduating from Karachi University, Pakistan, he earned a B.Sc. in Chemistry followed by an M.Sc. in Organic Chemistry. His academic journey culminated in 1996 with a PhD in Organic Chemistry from the Swiss Federal Institute of Technology (ETH) Zurich.
Afterward, Dr. Alzeer embarked on a diverse professional path. He began by contributing to research at Hoffmann La Roche before assuming roles as a Research Associate at both Michigan University and the University of Zurich. His career further evolved as he served as a senior scientist at the Swiss healthcare company, Lipomed, from 2009 to 2010. Following this, he transitioned into academia, holding an Assistant Professorship at Palestine Polytechnic University from 2010 to 2012.
In 2014, Dr. Alzeer founded the Swiss Scientific Society for Developing Countries, demonstrating his commitment to fostering scientific collaboration and development. Four years later, he introduced a groundbreaking concept in medicine termed "Halalopathy." Initially focused on developing novel anti-cancer drugs, Dr. Alzeer pioneered the utilization of natural products and solvent extraction techniques, aiming to formulate cancer treatments derived from natural sources.
Driven by a quest for meticulous recovery, Dr. Alzeer delved into the concept's essence, contemplating its reproducibility. This exploration led him to innovate the concept of Halalopathy, a medical approach that emphasizes entropy reduction as a cornerstone for prevention and cure. He posits that miraculous recoveries and spontaneous remissions are achievable through practices such as prayer, meditation, stress management, yoga, and mindfulness, all geared towards lowering the body's entropy.
Dr. Jawad Alzeer is not only the founder of Halalopathy but also a proponent of "lifestylopathy" medicine, advocating for holistic lifestyle interventions to optimize health outcomes.
Afterward, Dr. Alzeer embarked on a diverse professional path. He began by contributing to research at Hoffmann La Roche before assuming roles as a Research Associate at both Michigan University and the University of Zurich. His career further evolved as he served as a senior scientist at the Swiss healthcare company, Lipomed, from 2009 to 2010. Following this, he transitioned into academia, holding an Assistant Professorship at Palestine Polytechnic University from 2010 to 2012.
In 2014, Dr. Alzeer founded the Swiss Scientific Society for Developing Countries, demonstrating his commitment to fostering scientific collaboration and development. Four years later, he introduced a groundbreaking concept in medicine termed "Halalopathy." Initially focused on developing novel anti-cancer drugs, Dr. Alzeer pioneered the utilization of natural products and solvent extraction techniques, aiming to formulate cancer treatments derived from natural sources.
Driven by a quest for meticulous recovery, Dr. Alzeer delved into the concept's essence, contemplating its reproducibility. This exploration led him to innovate the concept of Halalopathy, a medical approach that emphasizes entropy reduction as a cornerstone for prevention and cure. He posits that miraculous recoveries and spontaneous remissions are achievable through practices such as prayer, meditation, stress management, yoga, and mindfulness, all geared towards lowering the body's entropy.
Dr. Jawad Alzeer is not only the founder of Halalopathy but also a proponent of "lifestylopathy" medicine, advocating for holistic lifestyle interventions to optimize health outcomes.
less
Uploads
Papers by Jawad Alzeer